Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) Other Non Operating Income (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Other Non Operating Income for 5 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income fell 6.78% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, up 32.21% year-over-year, with the annual reading at $2.0 million for FY2025, 25.14% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $2.0 million at Werewolf Therapeutics, up from $11000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $2.2 million in Q4 2024, with the low at -$1.1 million in Q1 2023.
  • Average Other Non Operating Income over 5 years is $188875.0, with a median of $1000.0 recorded in 2022.
  • The sharpest move saw Other Non Operating Income tumbled 6812.5% in 2023, then skyrocketed 16900.0% in 2025.
  • Over 5 years, Other Non Operating Income stood at -$17000.0 in 2021, then soared by 511.76% to $70000.0 in 2022, then crashed by 135.71% to -$25000.0 in 2023, then surged by 8772.0% to $2.2 million in 2024, then fell by 6.78% to $2.0 million in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $2.0 million, $11000.0, and $168000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.